Drug Shortage Report for NORITATE

Last updated on 2024-03-06 History
Report ID 213952
Drug Identification Number 02156091
Brand name NORITATE
Common or Proper name NORITATE
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) METRONIDAZOLE
Strength(s) 1%
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging size 45g
ATC code D06BX
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-01-25
Actual start date 2024-01-26
Estimated end date 2024-03-16
Actual end date 2024-03-05
Shortage status Resolved
Updated date 2024-03-06
Company comments Capacity problem in production
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-03-06 English Compare
v9 2024-03-05 French Compare
v8 2024-03-05 English Compare
v7 2024-02-01 French Compare
v6 2024-02-01 English Compare
v5 2024-01-26 English Compare
v4 2024-01-22 French Compare
v3 2024-01-22 English Compare
v2 2023-12-20 French Compare
v1 2023-12-20 English Compare

Showing 1 to 10 of 10